Loading
SP
Stellar Pharmaceuticals Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Harris Robert Paul, was filed 20 Mar 2013.
Stellar Pharmaceuticals Inc: what insiders have been doing
Stellar Pharmaceuticals Inc is a listed company. Its directors and officers file their transactions with SEC (Form 4). The past year has been quiet: not a single insider filing for Stellar Pharmaceuticals Inc. The previous disclosure was published on 20 March 2013.
Since 2006, the database holds 48 purchases and 18 sales by insiders of the company.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
100
Thresholds
n/a
Buy Volume
€2M
48 ops. · all time
Sell Volume
€120,705
18 ops. · all time
Last declaration on 20 March 2013
Declarations100 total
550,000 shares@ US$0.56Common SharesSEC:0001537250-13-000002:0
Canonical exit: 20 Jun 2012 (T+90)
625,000 shares@ US$0.40Common SharesSEC:0001537250-13-000002:2
Canonical exit: 28 May 2013 (T+90)
625,000 sharesCommon SharesSEC:0001140361-13-010902:0
Canonical exit: 2 Jun 2013 (T+90)
1,250,000 sharesCommon SharesSEC:0001140361-13-010902:1
Canonical exit: 2 Jun 2013 (T+90)
625,000 sharesCommon SharesSEC:0001140361-13-010902:2
Canonical exit: 2 Jun 2013 (T+90)
1,250,000 sharesCommon SharesSEC:0001140361-13-010904:0
Canonical exit: 2 Jun 2013 (T+90)
625,000 sharesCommon SharesSEC:0001140361-13-010904:1
Canonical exit: 2 Jun 2013 (T+90)
625,000 sharesCommon SharesSEC:0001140361-13-010904:2
Canonical exit: 2 Jun 2013 (T+90)
62,500 shares@ US$0.40Common ShareSEC:0001536874-13-000002:0
Canonical exit: 28 May 2013 (T+90)
1,250,000 shares@ US$0.40Common SharesSEC:0001357211-13-000003:0
Canonical exit: 28 May 2013 (T+90)
250,000 shares@ US$0.40Common SharesSEC:0001357211-13-000002:0
Canonical exit: 28 May 2013 (T+90)
550,000 shares@ US$0.40Common SharesSEC:0001357211-13-000004:0
Canonical exit: 28 May 2013 (T+90)
700,000 shares@ US$0.40Common SharesSEC:0001357211-13-000004:1
Canonical exit: 28 May 2013 (T+90)
900,000 shares@ US$0.56Common SharesSEC:0001536874-13-000001:0
Canonical exit: 20 Jun 2012 (T+90)
100,000 shares@ US$0.35Common SharesSEC:0001357211-12-000008:0
Canonical exit: 17 Feb 2013 (T+90)
25,000 shares@ US$0.50Common SharesSEC:0001357211-12-000006:0
Canonical exit: 6 Dec 2012 (T+90)
20,500 shares@ US$0.50Common ShareSEC:0001357211-12-000005:0
Canonical exit: 3 Dec 2012 (T+90)
44,500 shares@ US$0.50Common SharesSEC:0001357211-12-000005:1
Canonical exit: 4 Dec 2012 (T+90)
30,000 shares@ US$0.49Common SharesSEC:0001357211-12-000005:2
Canonical exit: 4 Dec 2012 (T+90)
10,000 shares@ US$0.505Common SharesSEC:0001357211-12-000005:3
Canonical exit: 4 Dec 2012 (T+90)
15,000 shares@ US$0.46Common SharesSEC:0001357211-12-000004:0
Canonical exit: 29 Nov 2012 (T+90)
5,000 shares@ US$0.489Common SharesSEC:0001357211-12-000004:1
Canonical exit: 29 Nov 2012 (T+90)
15,000 shares@ US$0.49Common SharesSEC:0001357211-12-000004:2
Canonical exit: 29 Nov 2012 (T+90)
10,000 shares@ US$0.425Common SharesSEC:0001140361-12-038832:0
Canonical exit: 25 Nov 2012 (T+90)
5,000 shares@ US$0.43Common SharesSEC:0001140361-12-038832:1
Canonical exit: 25 Nov 2012 (T+90)
25 of 100 declarations
About Stellar Pharmaceuticals Inc
Stellar Pharmaceuticals Inc is a company focused on the development and commercialization of pharmaceutical products. It is listed on NASDAQ under the ticker XNAS.
